Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the melanoma treatment study, including its eligibility criteria, locations, study design, outcomes, and registration details, instead of a 403 error.
    Difference
    53%
    Check dated 2026-11-09T12:59:54.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:41:17.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T13:51:59.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:55:15.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study record still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:07:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record and site navigation with an access-denied screen, which prevents viewing the trial details.
    Difference
    19%
    Check dated 2026-09-21T20:55:40.000Z thumbnail image

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.